Merck Serono Forms VC Group
Merck Serono, a division of Merck KGaA, has formed a corporate venture capital group that will invest in biotech startups. Named Merck Serono Ventures, the effort is initially capitalized with €40 million. Areas of particular interest include neurodegenerative diseases, oncology, autoimmune diseases and inflammatory diseases.
23 March 2009•3 mins read
